Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-04-10
2007-04-10
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S326000
Reexamination Certificate
active
10357252
ABSTRACT:
This invention provides FSH analogues having increased serum half-life relative to FSH. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject.
REFERENCES:
patent: 5585345 (1996-12-01), Boime
patent: 5712122 (1998-01-01), Boime et al.
patent: 5759818 (1998-06-01), Boime
patent: 5958737 (1999-09-01), Boime et al.
patent: 5985611 (1999-11-01), Boime
patent: 6225449 (2001-05-01), Boime
patent: 6242580 (2001-06-01), Boime et al.
patent: 6306654 (2001-10-01), Boime et al.
P. Wynn, et al. Human Reprod. (1998) 13(11), pp. 3132-3138.
E.H.Y. Ng, et al. Human Reprod. (2001) 16(2), pp. 319-325.
H.J. Out, et al. Human Reprod. (2000) 15(1), pp. 29-35.
R.R. Yeoman, et al. Biol. Reprod. (1994) 50, pp. 329-335.
K.B. Gilchrist, et al. Biol. Reprod. (1997) 56, pp. 238-246.
B. Frydman, et al. Human Reprod. (2000) 15(3), pp. 520-525.
A.L. Mikkelsen, et al. Human Reprod. (2000) 15(8), pp. 1685-1690.
Bouloux, P. M., D. J. Handelsman, F. Jockenhovel, E. Nieschlag, J. Rabinovici, W. L. Frasa, J. J. de Bie, G. Voortman, and J. Itskovitz-Eldor (2001) First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.Hum. Reprod. 16, 1592-1597.
Calvo, F. O., H. T. Keutmann, E. R. Bergert, and R. J. Ryan (1986) Deglycosylated human follitropin: characterization and effects on adenosine cyclic 3′,5′-phosphate production in porcine granulosa cells.Biochemistry25, 3938-3943.
Chui, D. K., N. D. Pugh, S. M. Walker, L. Gregory, and R. W. Shaw (1997) Follicular vascularity-the predictive value of transvaginal power Doppler ultrasonography in an in vitro fertilization programme: a preliminary study.Hum. Reprod. 12, 191-196.
Dissen, G. A., H. E. Lara, W. H. Fahrenbach, M. E. Costa, and S. R. Ojeda (1994) Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression.Endocrinology134, 1146-1154.
Fares, F. A., N. Suganuma, K. Nishimori, P. S. Lapolt, A. J. Hsueh, and I. Boime (1992) Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.Proc. Natl. Acad. Sci. U.S.A. 89, 4304-4308.
Feng, W., M. M. Matzuk, K. Mountjoy, E. Bedows, R. W. Ruddon, and I. Boime (1995) The asparagine-linked oligosaccharides of the human chorionic gonadotropin beta subunit facilitate correct disulfide bond pairing.J. Biol. Chem. 270, 11851-11859.
Ferrara, N., H. Chen, T. Davis-Smyth, H. P. Gerber, T. N. Nguyen, D. Peers, V. Chisholm, K. J. Hillan, and R. H. Schwall (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis.Nat. Med. 4, 336-340.
Ferrara, N., K. Houck, L. Jakeman, and D. W. Leung (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins.Endocr. Rev. 13, 18-32.
Krichevsky, A., S. Birken, J. F. O'Connor, K. Bikel, J. Schlatterer, and R. E. Canfield (1994) The development of a panel of monoclonal antibodies to human luteinizing hormone and its application to immunological mapping and two-site assays.Endocrine 2. 511-520.
LeContonnec, J.Y., H.C. Porchet, V. Beltrami, A. Khan, S. Toon, and M. Rowland (1994) Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady-state pharmacokinetics.Fertil. Steril. 61, 679-86.
Lindau-Shapard, B.A., H.A. Brumberg, A.J. Peterson, and J.A. Dias (2001) Reversible immunoneutralization of human follitropin receptor.J. Reprod. Immun. 49, 1-19.
Matzuk, M. M., A. J. Hsueh, P. Lapolt, A. Tsafriri, J. L. Keene, and I. Boime (1990) The biological role of the carboxyl-terminal extension of human chorionic gonadotropin beta-subunit.Endocrinology126, 376-383.
Nargund, G., T. Bourne, P. Doyle, J. Parsons, W. Cheng, S. Campbell, and W. Collins (1996) Associations between ultrasound indices of follicular blood flow, oocyte recovery and preimplantation embryo quality.Hum. Reprod. 11, 109-113.
Pedersen, T. and H. Peters (1968) Proposal for a classification of oocytes and follicles in the mouse ovary.J. Reprod. Fertil. 17, 555-557.
Pierce, J. G. and T. F. Parsons (1981) Glycoprotein hormones: structure and function.Annu. Rev. Biochem. 50, 465-495.
Porchet, H.C., J.Y. LeContonnec, B. Neuteboom, S. Canali, and G. Zanolo (1995) Pharmacokinetics of recombinant human luteinizing hormone.J. Clin. Endocrinol. Metab. 80, 667-73.
Saal, W., H.J. Glowania, and J. Happ (1991) Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin.Fertil. Steril. 56, 225-8.
Sairam, M. R. and P. Manjunath (1982) Studies on pituitary follitropin. XL Induction of hormonal antagonistic activity by chemical deglycosylation.Mol. Cell Endocrinol. 28, 139-150.
Sugahara, T., M. R. Pixley, F. Fares, and I. Boime (1996) Characterization of the O-glycosylation sites in the chorionic gonadotropin beta subunit in vivo using site-directed mutagenesis and gene transfer.J. Biol. Chem. 271, 20797-20804.
Suganuma, N., M. M. Matzuk, and I. Boime (1989) Elimination of disulfide bonds affects assembly and secretion of the human chorionic gonadotropin beta subunit.J. Biol. Chem. 264, 19302-19307.
Van Blerkom, J., M. Antczak, and R. Schrader (1997) The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics.Hum. Reprod. 12, 1047-1055; and.
Yen, S. S., O. Llerena, B. Little, and O. H. Pearson (1968) Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man.J. Clin. Endocrinol. Metab. 28, 1763-1767.
International Search Report issued Dec. 1, 2003 in connection with PCT International Application No. PCT/US03/02982: and.
Ben-Menahem et al. (2001) The Position of the Alpha and Beta Subunits in a Single Chain Variant of Human Chorionic Gonadotropin Affects the Heterodimeric Interaction of the Subunits and Receptor-Binding Epitope. J. Biol. Chem. 276:29871-879.
Cooper & Dunham LLP
Kosar Andrew D.
The Trustees of Columbia University in the City of New York
Tsang Cecilia J.
White John P.
LandOfFree
Long-acting follicle stimulating hormone analogues and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long-acting follicle stimulating hormone analogues and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long-acting follicle stimulating hormone analogues and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3752580